Jefferies Initiates Coverage On Compass Pathways with Buy Rating, Announces Price Target of $18

Jefferies analyst Andrew Tsai initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Buy rating and announces Price Target of $18.